Consensus Guardant Health, Inc.

Equities

GH

US40131M1099

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-19 pm EDT			5-day change	1st Jan Change
16.07 ^USD	-3.60%		-11.99%	-40.59%

Apr. 15	Goldman Sachs Adjusts Guardant Health Price Target to $28 From $32, Maintains Buy Rating	MT
Apr. 03	Guardant Health to Present Data Highlighting Application of Epigenomics to Advance Precision Oncology at 2024 AACR Annual Meeting	CI

Evolution of the average Target Price on Guardant Health, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e8caafc0793c813d1c91084.lpAgVR988OxB4jN0jI6Q1OjYI8UByNUurQn_uoTce64.pPdBN3IOlYkTjUUnyt79ncXpRPE2jb522EKW--q4GOLjpUEAdB2coQihXA~7e01ba4aec814b441e93a1c7d9344816

Analyst Recommendations on Guardant Health, Inc.

Goldman Sachs Adjusts Guardant Health Price Target to $28 From $32, Maintains Buy Rating	Apr. 15	MT
Piper Sandler Cuts Price Target on Guardant Health to $30 From $40, Maintains Overweight Rating	Feb. 26	MT
UBS Adjusts Guardant Health Price Target to $32 From $45, Maintains Buy Rating	Feb. 23	MT
Canaccord Genuity Adjusts Price Target on Guardant Health to $45 From $50, Maintains Buy Rating	Feb. 23	MT
Goldman Sachs Cuts Price Target on Guardant Health to $37 From $43, Maintains Buy Rating	Jan. 29	MT
Raymond James Upgrades Guardant Health to Outperform From Market Perform, Price Target is $27	Nov. 13	MT
Morgan Stanley Cuts Price Target on Guardant Health to $50 From $55, Keeps Overweight Rating	Nov. 08	MT
UBS Adjusts Guardant Health Price Target to $45 From $44, Maintains Buy Rating	Nov. 07	MT
Goldman Sachs Cuts Price Target on Guardant Health to $45 From $52, Keeps Buy Rating	23-10-23	MT
BofA Securities Adjusts Price Target on Guardant Health to $46 From $57, Maintains Buy Rating	23-10-20	MT
Goldman Sachs Lowers Price Target on Guardant Health to $45 From $52, Maintains Buy Rating	23-10-20	MT
Guardant Health Shares Climb After Bernstein Initiates Coverage With Outperform Rating	23-09-28	MT
Bernstein Starts Guardant Health With Outperform Rating	23-09-28	MT
Piper Sandler Upgrades Guardant Health to Overweight From Neutral	23-09-27	MT
UBS Adjusts Guardant Health Price Target to $44 From $43, Maintains Buy Rating	23-08-08	MT
Morgan Stanley Adjusts Guardant Health's Price Target to $55 From $60, Keeps Overweight Rating	23-08-07	MT
Citigroup Adjusts Guardant Health's Price Target to $50 From $40, Keeps Buy Rating	23-08-04	MT
Citigroup Upgrades Guardant Health to Buy From Neutral, Adjusts Price Target to $40 From $28	23-05-26	MT
UBS Adjusts Guardant Health Price Target to $43 From $40, Maintains Buy Rating	23-05-12	MT
Morgan Stanley Adjusts Price Target on Guardant Health to $60 From $66, Maintains Overweight Rating	23-05-11	MT
Credit Suisse Lowers Guardant Health's Price Target to $55 From $60 to Reflect SHIELD Uncertainty, Keeps Outperform Rating	23-05-10	MT
UBS Initiates Coverage on Guardant Health With Buy Rating, $40 Price Target	23-05-05	MT
Citigroup Downgrades Guardant Health to Neutral From Buy, Cuts Price Target to $33 From $60	23-03-09	MT
Piper Sandler Adjusts Guardant Health's Price Target to $35 From $50, Keeps Neutral Rating	23-03-03	MT
Morgan Stanley Adjusts Price Target on Guardant Health to $66 From $73, Maintains Overweight Rating	23-02-27	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

16.67 USD

Average target price

40.12 USD

Spread / Average Target

+140.70%

High Price Target

50 USD

Spread / Highest target

+199.94%

Low Price Target

27 USD

Spread / Lowest Target

+61.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Guardant Health, Inc.

Goldman Sachs
Piper Sandler
UBS
Canaccord Genuity
Raymond James
Morgan Stanley
BofA Securities
Bernstein
Citigroup
Credit Suisse
Scotiabank
Cowen
BTIG
JPMorgan Chase
Stephens Inc.
Craig-Hallum
SVB Leerink
Stifel Nicolaus
Wells Fargo Securities

Ratings for Guardant Health, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar